Practice 8 Flashcards

1
Q

Which of the following are SAFETY monitoring parameters of pravastatin therapy? SATA

  1. Serum Bilirubin
  2. GI upset
  3. Myalgias
  4. Myopathy
A

GI upset
Myalgias
Myopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Which of the following are SAFETY monitoring parameters of simvastatin therapy? SATA

  1. Creatine phosphokinase (CPK)
  2. Lipids
  3. Serum Bilirubin
  4. LFTs
A
Creatine phosphokinase (CPK)
LFTs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Which of the following SAFETY monitoring parameters of gemfibrozil therapy? SATA

  1. Creatine phosphokinase (CPK)
  2. Lipids
  3. Serum Bilirubin
  4. LFTs
A

Creatine phosphokinase (CPK)
Serum Bilirubin
LFTs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Gemfibrozil is contraindicated in patients who have primary biliary cirrhosis. T/F

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Rosuvastatin is contraindicated in patients who are pregnant. T/F

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Lipitor is lipid-regulating agent that decreases LDL and decreases HDL. T/F

A

False

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Lopid is lipid-regulating agent that decreases serum triglycerides and decreases HDL. T/F

A

False

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Atorvastatin is a CYP 3A4 inhibitor. T/F

A

False

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Gemfibrozil is a 2C19 inhibitor. T/F

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Which of the following medications inhibit CYP 2C9? SATA

  1. Lipitor
  2. Lopid
  3. Crestor
  4. Tricor
A

Lopid

Tricor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly